CVS Health (CVS) Q4 Results: Anticipated Outcomes

CVS Health Set to Release Earnings: What Investors Should Know

CVS Health (NYSE:CVS), a leading player in the healthcare sector, is scheduled to announce its latest earnings this Tuesday morning. Here’s a breakdown of what the market is anticipating.

In the previous quarter, CVS Health delivered a strong performance, surpassing revenue forecasts by 4.1%. The company posted $102.9 billion in revenue, marking a 7.8% increase compared to the same period last year. Both revenue and earnings per share came in ahead of analyst projections, making it a standout quarter for the company.

For the upcoming quarter, analysts predict that CVS Health’s revenue will reach $103.7 billion, representing a 6.1% year-over-year increase—an improvement over last year’s 4.2% growth for the same period. Adjusted earnings per share are expected to be $1.00.

Analyst Sentiment and Historical Performance

Over the past month, most analysts have maintained their forecasts for CVS Health, indicating confidence in the company’s direction as it approaches earnings. However, it’s worth noting that CVS Health has fallen short of Wall Street’s revenue expectations twice in the last two years.

Industry Peers and Recent Results

Several of CVS Health’s competitors in the health insurance space have already released their fourth-quarter results, offering some insight into sector trends. Cigna reported a 10.4% year-over-year revenue increase, beating estimates by 3.8%, while Centene saw its revenue climb 21.9%, exceeding forecasts by 3%. Following its report, Cigna’s stock price rose by 7.5%.

Market Trends and CVS Health’s Position

While the stock market initially surged following Trump’s November victory, concerns about possible tariffs have led to increased volatility in 2025. Although some health insurance stocks have shown resilience, the sector as a whole has lagged, with average share prices dropping 3.1% over the past month. CVS Health’s stock has declined 2.8% during this period. The average analyst price target for CVS Health stands at $94.76, compared to its current price of $78.24.

Spotlight on Growth Opportunities

At StockStory, we recognize the value of investing in major trends. Companies like Microsoft (MSFT), Alphabet (GOOG), Coca-Cola (KO), and Monster Beverage (MNST) have all benefited from powerful growth drivers. In this spirit, we’ve identified a lesser-known, profitable growth stock poised to benefit from the rise of AI—and you can access our pick for free through the provided link.